US 12290531
Compositions targeting BCMA and methods of use thereof
granted A61KA61K2039/505A61K2239/13
Quick answer
US patent 12290531 (Compositions targeting BCMA and methods of use thereof) held by Takeda Pharmaceutical Company Limited expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K2239/13, A61K2239/21, A61K2239/25